Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Frank

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
ACP Journal Club|January 4, 2008
Review: Prophylactic use of granulocyte colony-stimulating factor reduces febrile neutropenia and short-term mortality in cancerDavid A Frank
Idrugs : the Investigational Drugs Journal|January 8, 2009
Targeting transcription factors for cancer therapyDavid A Frank
Cancer Letters|November 30, 2006
STAT3 as a central mediator of neoplastic cellular transformationDavid A Frank
Blood|August 8, 2009
STAT6 in PMBL: pathogenic or passenger?David A Frank
Cancer Treatment and Research|March 5, 2003
StAT signaling in cancer: insights into pathogenesis and treatment strategiesDavid A Frank
JAK-STAT|September 24, 2013
Targeting STATs for cancer therapy: "Undruggable" no moreDavid A Frank
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Transcription factor STAT3 as a prognostic marker and therapeutic target in cancerDavid A Frank
Cancer Research|April 4, 2022
Cyclin-Dependent Kinase 4/6 Inhibitors: Is a Noncanonical Substrate the Key Target?David A Frank
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapyDoris Germain, David A Frank
Neoplasia (New York, N.Y.)|November 3, 2021
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implicationsIsidora Tošić, David A Frank
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
ACP Journal Club|January 4, 2008
Review: Prophylactic use of granulocyte colony-stimulating factor reduces febrile neutropenia and short-term mortality in cancerDavid A Frank
Idrugs : the Investigational Drugs Journal|January 8, 2009
Targeting transcription factors for cancer therapyDavid A Frank
Cancer Letters|November 30, 2006
STAT3 as a central mediator of neoplastic cellular transformationDavid A Frank
Blood|August 8, 2009
STAT6 in PMBL: pathogenic or passenger?David A Frank
Cancer Treatment and Research|March 5, 2003
StAT signaling in cancer: insights into pathogenesis and treatment strategiesDavid A Frank
JAK-STAT|September 24, 2013
Targeting STATs for cancer therapy: "Undruggable" no moreDavid A Frank
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Transcription factor STAT3 as a prognostic marker and therapeutic target in cancerDavid A Frank
Cancer Research|April 4, 2022
Cyclin-Dependent Kinase 4/6 Inhibitors: Is a Noncanonical Substrate the Key Target?David A Frank
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapyDoris Germain, David A Frank
Neoplasia (New York, N.Y.)|November 3, 2021
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implicationsIsidora Tošić, David A Frank
Pageof 13